Wantai Bio: Cumulative repurchase of about 510,000 shares, accounting for 0.056%

Every time AI News, Wantai Bio (SH 603392, closing price: 131.5 yuan) issued an announcement on the evening of September 1 that as of August 31, 2022, the company has accumulated a total of about 510,000 shares by concentrated bidding transactions. The proportion of repurchase shares accounted for 0.056%, the highest price of repurchase transactions was 130 yuan/share, the lowest price was 125.28 yuan/share, and the total amount of funds paid was about 64.97 million yuan.

From January to December 2021, the operating income of Wantai Biological is 58.48%of the vaccine and 40.68%of in vitro diagnosis.

The general manager and chairman of Wantai Bio are Qiu Zixin, male, 59 years old, and the background of his education is undergraduate.

As of press time, Wantai's biological market value was 119.1 billion yuan.

Daeda1997 "Single Stock Trends" reminder:

1. Wantai Bio has a decrease of the shareholding of the north -northern direction of the north within 30 days, the shares of the shares accounting for 0.92%;

2. In the past 30 days, there was no opportunity to investigate Wantai Bio.

For more stock trend information, please search for the WeChat public account "Daida", reply "Query", and receive free query permissions!

Every headline (NBDTOUTIAO) -just announced that the largest household holding of Yu'ebao's largest households fell more than 20 million yuan, and earning 5 million yuan a year will not be!

(Reporter Zhang Xiwei)

Disclaimer: The content and data of this article are for reference only, and do not constitute investment suggestions. Please verify before use. Based on this, the risk is on its own.

Daily Economic News

- END -